9JS2 の概要
| エントリーDOI | 10.2210/pdb9js2/pdb |
| 分子名称 | 4-hydroxyphenylpyruvate dioxygenase, 1,5-dimethyl-6-(2-oxidanyl-6-oxidanylidene-cyclohexen-1-yl)carbonyl-3-propoxy-quinoxalin-2-one, COBALT (II) ION, ... (4 entities in total) |
| 機能のキーワード | inhibitor, complex, oxidoreductase, oxidoreductase-oxidoreductase inhibitor complex, oxidoreductase/oxidoreductase inhibitor |
| 由来する生物種 | Arabidopsis thaliana (thale cress) |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 44771.16 |
| 構造登録者 | |
| 主引用文献 | Cai, Z.M.,Ying, R.N.,Wang, X.Q.,Bai, R.Y.,Sun, A.,Kandegama, W.,Lin, H.Y.,Wang, D.W.,Yang, G.F. Design, Synthesis, and Bioactivity of Triketone-quinoxalin-2-ones as a Novel HPPD Inhibition Herbicide. J.Agric.Food Chem., 73:27328-27337, 2025 Cited by PubMed Abstract: 4-Hydroxyphenylpyruvate dioxygenase (HPPD) is recognized as one of the most promising herbicide targets for sustainable weed control in modern agricultural practices. To address agricultural demands, we designed and synthesized a novel series of triketone-quinoxalin-2-ones as potent HPPD inhibitors. In vitro evaluation revealed that the newly synthesized compounds demonstrated remarkable HPPD (HPPD) inhibitory activity. Significantly, compound , 3-(4-chloro-2-fluorophenyl)-6-(2-hydroxy-6-oxocyclohex-1-ene-1-carbonyl)-1,5-dimethylquinoxalin-2(1)-one, showed the strongest HPPD inhibition with an IC value of 0.034 μM, 10-fold more potent than mesotrione (IC = 0.350 μM). Furthermore, the postemergence herbicidal activity evaluation showed that compound exhibited 100% inhibition of , , , and at 150 g ai/ha, and 90% inhibition of , showing enhanced activity compared to mesotrione. The crystal structure of the HPPD complex demonstrated that compound engaged in a key bidentate chelating interaction with the metal ion in the catalytic active site and a π-π interaction with Phe381 and Phe424. Moreover, established hydrophobic interactions with Leu427, Leu368, and Met335. These results indicate that the triketone-quinoxalin-2-one hybrid is a promising scaffold and can be considered a viable lead compound for the development of HPPD inhibitors. PubMed: 41100756DOI: 10.1021/acs.jafc.5c08188 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.94 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






